Conroy, with a 32-slide presentation deck also detailed the growth opportunities for Exact in other vital detection markets like pancreatic, esophageal, bladder, ovarian, cervical, stomach, lung, lymphoma, melanoma, kidney, and uterine cancers.Intelligent Diagnostics Recently, I recommended Exact Sciences to investors as a healthcare "AI" play because the use of data mining, modeling, and machine learning (ML) in detecting and treating cancer will continue to be a growing trend.